Ngenla Contraindications

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Contraindications

Based on experience with daily growth hormone products, NGENLA is contraindicated in patients with active tumors and/or malignancy.
Based on experience with pharmacologic amounts of daily growth hormone products, NGENLA is contraindicated in patients with acute critical illness due to complications following open heart or abdominal surgery, multiple accidental trauma, or acute respiratory failure (see Precautions).
NGENLA is contraindicated in patients with known hypersensitivity to somatrogon (see Precautions) or any of its excipients (see Description).

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma